Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer

Authors

  • Malgorzata K. Tuxen Department of Oncology, Herlev University Hospital, Herlev, Denmark
  • Soeren Cold Department of Oncology, Odense University Hospital, Odense, Denmark
  • Ulla B. Tange Department of Oncology, Rigshospitalet, Copenhagen, Denmark
  • Eva Balslev Department of Pathology, Herlev University Hospital, Herlev, Denmark
  • Dorte L. Nielsen Department of Oncology, Herlev University Hospital, Herlev, Denmark

DOI:

https://doi.org/10.3109/0284186X.2014.921727

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2014-10-01

How to Cite

Tuxen, M. K., Cold, S., Tange, U. B., Balslev, E., & Nielsen, D. L. (2014). Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer. Acta Oncologica, 53(10), 1440–1445. https://doi.org/10.3109/0284186X.2014.921727

Issue

Vol. 53 No. 10 (2014): Acta Oncologica

Section

Articles